Monica Agarwal, MD
Family Practice · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Permanente Medical Group Inc · 10,928 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Agarwal’s office at (408) 972-6931 to ask if they take your plan before you enroll.
California Medical Board record
Licence A183566 · Current
Licensed to practise in California · since 2022 · expires 2026-12-31 · Rutgers, Robert Wood Johnson Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
State licence records
1 licence
- New Jersey 25MA11176100Medical Doctor · since 2021 · expires 2023-06-30ExpiredNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Medicaid work
$3,063 in 2024
Medicaid paid $3,063 for 56 billed services this clinician did in 2024, up to 16 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 43 | $3,063 |
| TOBACCO NON-USER | 13 | $0 |
| 2024 | 56 | 2 | 16 | $3,063 |
| 2023 | 12 | 1 | 12 | $0 |
See the largest Medicaid services in earlier years
2023
| Short return visit (20+ min) | 12 | $0 |
Drugs they prescribed that Part D paid
$105,634
Pharmacies billed $105,634 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 2% of their Part D prescriptions (43 of 2,374) in 2024. Above the middle of the specialty; the typical family practice clinician is at 2%.
2,155 generic and 205 brand-name prescriptions · $105,634 in drug cost · 62 antibiotic prescriptions to 46 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Jardiance | 21 | $11,286 | $537 |
| Spiriva Respimat | 18 | $10,614 | $590 |
| Ozempic | 12 | $10,166 | $847 |
| Wixela Inhub | 35 | $5,320 | $152 |
| Pradaxa | 17 | $2,907 | $171 |
See all 50 drugs
| Jardiance | 21 | $11,286 | $537 |
| Spiriva Respimat | 18 | $10,614 | $590 |
| Ozempic | 12 | $10,166 | $847 |
| Wixela Inhub | 35 | $5,320 | $152 |
| Pradaxa | 17 | $2,907 | $171 |
| Atorvastatin | 194 | $2,250 | $12 |
| Losartan | 128 | $2,126 | $17 |
| Alvesco | 11 | $2,017 | $183 |
| Levothyroxine | 95 | $1,803 | $19 |
| Fluticasone Propionate | 55 | $1,148 | $21 |
| Albuterol Sulfate Hfa | 63 | $1,114 | $18 |
| Amlodipine Besylate | 95 | $1,089 | $11 |
| Gabapentin | 47 | $1,087 | $23 |
| Lisinopril | 79 | $1,081 | $14 |
| Famotidine | 72 | $887 | $12 |
| Terazosin | 19 | $870 | $46 |
| Tamsulosin | 38 | $767 | $20 |
| Rosuvastatin | 55 | $642 | $12 |
| Hydrochlorothiazide | 49 | $579 | $12 |
| Metformin | 48 | $576 | $12 |
| Trazodone | 37 | $573 | $15 |
| Sertraline | 25 | $569 | $23 |
| Omeprazole | 45 | $546 | $12 |
| Atenolol | 41 | $539 | $13 |
| Hydrocodone-Acetaminophen | 29 | $504 | $17 |
| Metoprolol | 45 | $490 | $11 |
| Tizanidine | 28 | $483 | $17 |
| Metoprolol | 42 | $471 | $11 |
| Naproxen | 46 | $470 | $10 |
| Simvastatin | 35 | $401 | $11 |
| Diltiazem 24hr Er (Cd) | 17 | $332 | $20 |
| Metformin Hcl Er | 37 | $326 | $9 |
| Hydralazine | 26 | $320 | $12 |
| Midodrine | 13 | $298 | $23 |
| Nortriptyline | 13 | $293 | $23 |
| Losartan-Hydrochlorothiazide | 24 | $270 | $11 |
| Alendronate | 26 | $255 | $10 |
| Finasteride | 15 | $235 | $16 |
| Glipizide | 24 | $226 | $9 |
| Montelukast | 20 | $226 | $11 |
| Furosemide | 14 | $203 | $14 |
| Isosorbide Mononitrate Er | 16 | $203 | $13 |
| Spironolactone | 12 | $195 | $16 |
| Allopurinol | 14 | $166 | $12 |
| Carvedilol | 14 | $164 | $12 |
| Lovastatin | 14 | $163 | $12 |
| Doxycycline Monohydrate | 13 | $137 | $11 |
| Fluoxetine | 11 | $135 | $12 |
| Pravastatin | 11 | $125 | $11 |
| Sulfamethoxazole-Trimethoprim | 11 | $62 | $6 |
Year by year
| 2024 | 2,374 | 390 | 2% (43) | 9% | $105,634 |
| 2023 | 728 | 186 | 2% (13) | None | $33,358 |
| 2022 | 14 | None | 0% (0) | None | $556 |
| 2021 | 314 | 39 | None | 10% | $13,791 |
| 2020 | 294 | 51 | None | None | $30,489 |
| 2019 | 156 | 39 | None | None | $12,328 |
| 2018 | 25 | None | None | None | $909 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 19 drugs
| Levothyroxine | 47 | $915 | $19 |
| Losartan | 47 | $850 | $18 |
| Atorvastatin | 52 | $764 | $15 |
| Estradiol | 11 | $507 | $46 |
| Albuterol Sulfate Hfa | 21 | $386 | $18 |
| Lisinopril | 29 | $333 | $11 |
| Amlodipine Besylate | 24 | $306 | $13 |
| Famotidine | 19 | $299 | $16 |
| Gabapentin | 14 | $282 | $20 |
| Fluticasone Propionate | 20 | $278 | $14 |
| Diltiazem 24hr Er (Cd) | 12 | $268 | $22 |
| Metformin | 17 | $192 | $11 |
| Omeprazole | 15 | $189 | $13 |
| Naproxen | 18 | $182 | $10 |
| Sertraline | 16 | $176 | $11 |
| Hydrochlorothiazide | 12 | $153 | $13 |
| Rosuvastatin | 13 | $143 | $11 |
| Metoprolol | 11 | $109 | $10 |
| Losartan-Hydrochlorothiazide | 11 | $105 | $10 |
2021: 7 drugs
| Levothyroxine | 30 | $437 | $15 |
| Gabapentin | 13 | $290 | $22 |
| Atorvastatin | 15 | $193 | $13 |
| Amlodipine Besylate | 35 | $175 | $5 |
| Metformin Hcl Er | 12 | $118 | $10 |
| Lisinopril | 16 | $98 | $6 |
| Sertraline | 11 | $60 | $5 |
2020: 4 drugs
| Lantus Solostar | 11 | $4,777 | $434 |
| Atorvastatin | 26 | $420 | $16 |
| Amlodipine Besylate | 17 | $115 | $7 |
| Lisinopril | 17 | $70 | $4 |
2019: 1 drug
| Atorvastatin | 18 | $227 | $13 |
Money from drug and device companies
$100 in 2023
A payment is not proof that care is biased.
| Medicines360 | Liletta | $100 | 1 payment
|
See the published payment
| Medicines360 | Consulting · 2023-04-27 | Liletta | $100 |
Professional record
- NPI
- 1043716152
- Licence
- CA A183566, NJ 25MA11176100California A183566: Current · expires 2026-12-31New Jersey 25MA11176100: Expired
- Trained
- Rutgers R W Johnson Medical School (Cam/New Bruns/Pisc), 2018
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X); Student in a training program (390200000X)
- Mailing address
- 11 Bishop Pl, New Brunswick, NJ, 08901
- NPI first listed
- 2018-04-05
- NPI last updated
- 2023-12-11
- NPI record certified
- 2023-12-11
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.